Cryo-Cell International(CCEL) - 2020 Q3 - Quarterly Report

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value CCEL OTCQB Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐ FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended August 31, 2020 ☐ Transition report pursuant to Section 13 or ...